Table 6.

Treatment regimens of Autoimmune thrombocytopenia in patients who progressive CLL.

RCD	Rituximab 375mg/m2 IV on day 1; Cyclophosphamide 750mg/m2 on day 2; Dexamethasone 12 mg IV on days 1 and 2, and orally on days 3 through 7. These cycles were repeated every 3–4 weeks, depending upon recovery of blood counts.
R-CVP	Cyclophosphamide 750mg/m2, Vincristine 1.4 mg/m2 (maximum 2 mg) and Rituximab 375mg/m2 intravenously on day 1 and oral prednisone 40 mg/m2 days 1–5 of each 21 day cycle with the intent to treat with 6 cycles of therapy.